CTSS Contributes to Airway Neutrophilic Inflammation in Mixed Granulocytic Asthma

Overview

Journal Respir Res

Specialty Pulmonary Medicine

Date 2024 Dec 24

PMID 39719614

Authors

Haixiong Tang

Zhongli Li

Changyun Yang

Lin Fu

Xiaolong Ji

Zemin Chen

Sudan Gan

Hailing Zhang

Pingan Zhang

Shiyue Li

Wenjun Zhang

Xin Chen

Lihong Yao

Jing Li

Affiliations

Soon will be listed here.

Abstract

Background: Mixed granulocytic asthma (MGA) is usually associated with poor response to corticosteroid therapy and a high risk of severe asthma. Cathepsin S (CTSS) has been found to play an important role in various inflammatory diseases. This study was aimed to investigate the role of CTSS in MGA.

Methods: Induced sputum was obtained from healthy subjects and asthma patients. Two murine models of MGA were established using either TDI (toluene diisocyanate) alone or OVA emulsified in CFA. LY3000328, a specific antagonist of CTSS, was therapeutically given to BALB/c mice after airway challenge with TDI or OVA. The effects of recombinant CTSS was tested in vivo, and Akt inhibition was used to explore a possible mechanism for CTSS-induced airway inflammation.

Results: MGA patients have a significant higher sputum CTSS level than the health and subjects with other inflammatory phenotypes, which was positively correlated with sputum level of soluble E-cadherin (sE-cadherin), sputum neutrophils, FeNO, FEF25-75% and glucocorticoid dosage. Allergen exposure markedly increased CTSS level and pharmacological antagonism of CTSS with LY3000328 decreased airway hyperresponsiveness, airway neutrophil accumulation, as well as the release of IL-17 and sE-cadherin in murine models of MGA, yet had no effects on eosinophilic inflammation nor type 2 inflammatory cytokines (IL-4 and IL-5). In addition, intratracheal instillation of recombinant CTSS leads to neutrophil recruitment and overproduction of sE-cadherin in the lung tissues, which could be attenuated by inhibition of Akt signaling.

Conclusion: Our data suggested that CTSS contributes to airway neutrophilic inflammation in MGA through an Akt-dependent pathway.

References

Li C, Chen Q, Jiang Y, Liu Z . Single nucleotide polymorphisms of cathepsin S and the risks of asthma attack induced by acaroid mites. Int J Clin Exp Med. 2015; 8(1):1178-87. PMC: 4358566. View

Irvin C, Zafar I, Good J, Rollins D, Christianson C, Gorska M . Increased frequency of dual-positive TH2/TH17 cells in bronchoalveolar lavage fluid characterizes a population of patients with severe asthma. J Allergy Clin Immunol. 2014; 134(5):1175-1186.e7. PMC: 4254017. DOI: 10.1016/j.jaci.2014.05.038. View

Riese R, Mitchell R, Villadangos J, Shi G, PALMER J, Karp E . Cathepsin S activity regulates antigen presentation and immunity. J Clin Invest. 1998; 101(11):2351-63. PMC: 508824. DOI: 10.1172/JCI1158. View

Lewis C, Yang J, Huang X, Banerjee S, Blackburn M, Baluk P . Disease-specific gene expression profiling in multiple models of lung disease. Am J Respir Crit Care Med. 2007; 177(4):376-87. PMC: 2258439. DOI: 10.1164/rccm.200702-333OC. View

Hastie A, Moore W, Meyers D, Vestal P, Li H, Peters S . Analyses of asthma severity phenotypes and inflammatory proteins in subjects stratified by sputum granulocytes. J Allergy Clin Immunol. 2010; 125(5):1028-1036.e13. PMC: 2878277. DOI: 10.1016/j.jaci.2010.02.008. View

Xie L, Zhang S, Huang L, Peng Z, Lu H, He Q . Single-cell RNA sequencing of peripheral blood reveals that monocytes with high cathepsin S expression aggravate cerebral ischemia-reperfusion injury. Brain Behav Immun. 2022; 107:330-344. DOI: 10.1016/j.bbi.2022.11.001. View

Hamilton D, Lehman H . Asthma Phenotypes as a Guide for Current and Future Biologic Therapies. Clin Rev Allergy Immunol. 2019; 59(2):160-174. DOI: 10.1007/s12016-019-08760-x. View

R van Buul A, Taube C . Treatment of severe asthma: entering the era of targeted therapy. Expert Opin Biol Ther. 2015; 15(12):1713-25. DOI: 10.1517/14712598.2015.1084283. View

Wilder J, Collie D, Wilson B, Bice D, Lyons C, Lipscomb M . Dissociation of airway hyperresponsiveness from immunoglobulin E and airway eosinophilia in a murine model of allergic asthma. Am J Respir Cell Mol Biol. 1999; 20(6):1326-34. DOI: 10.1165/ajrcmb.20.6.3561. View

10.

Yip W, Seow H . Activation of phosphatidylinositol 3-kinase/Akt signaling by EGF downregulates membranous E-cadherin and β-catenin and enhances invasion in nasopharyngeal carcinoma cells. Cancer Lett. 2011; 318(2):162-72. DOI: 10.1016/j.canlet.2011.12.018. View

11.

Chen R, Zhang Q, Chen S, Tang H, Huang P, Wei S . IL-17F, rather than IL-17A, underlies airway inflammation in a steroid-insensitive toluene diisocyanate-induced asthma model. Eur Respir J. 2019; 53(4). DOI: 10.1183/13993003.01510-2018. View

12.

Hastie A, Mauger D, Denlinger L, Coverstone A, Castro M, Erzurum S . Mixed Sputum Granulocyte Longitudinal Impact on Lung Function in the Severe Asthma Research Program. Am J Respir Crit Care Med. 2021; 203(7):882-892. PMC: 8017570. DOI: 10.1164/rccm.202009-3713OC. View

13.

Fajardo I, Svensson L, Bucht A, Pejler G . Increased levels of hypoxia-sensitive proteins in allergic airway inflammation. Am J Respir Crit Care Med. 2004; 170(5):477-84. DOI: 10.1164/rccm.200402-178OC. View

14.

Henderson Jr W, Chi E, Albert R, Chu S, Lamm W, Rochon Y . Blockade of CD49d (alpha4 integrin) on intrapulmonary but not circulating leukocytes inhibits airway inflammation and hyperresponsiveness in a mouse model of asthma. J Clin Invest. 1998; 100(12):3083-92. PMC: 508521. DOI: 10.1172/JCI119863. View

15.

Tang H, Guo Y, Gan S, Chen Z, Dong M, Lin L . GLUT1 mediates the release of HMGB1 from airway epithelial cells in mixed granulocytic asthma. Biochim Biophys Acta Mol Basis Dis. 2024; 1870(3):167040. DOI: 10.1016/j.bbadis.2024.167040. View

16.

Crimi E, Spanevello A, Neri M, Ind P, Rossi G, Brusasco V . Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma. Am J Respir Crit Care Med. 1998; 157(1):4-9. DOI: 10.1164/ajrccm.157.1.9703002. View

17.

Gans M, Gavrilova T . Understanding the immunology of asthma: Pathophysiology, biomarkers, and treatments for asthma endotypes. Paediatr Respir Rev. 2019; 36:118-127. DOI: 10.1016/j.prrv.2019.08.002. View

18.

Cosmi L, Liotta F, Annunziato F . Th17 regulating lower airway disease. Curr Opin Allergy Clin Immunol. 2015; 16(1):1-6. DOI: 10.1097/ACI.0000000000000227. View

19.

Goto Y, Uchida Y, Nomura A, Sakamoto T, Ishii Y, Morishima Y . Dislocation of E-cadherin in the airway epithelium during an antigen-induced asthmatic response. Am J Respir Cell Mol Biol. 2000; 23(6):712-8. DOI: 10.1165/ajrcmb.23.6.4031. View

20.

Deschamps K, Cromlish W, Weicker S, Lamontagne S, Huszar S, Gauthier J . Genetic and pharmacological evaluation of cathepsin s in a mouse model of asthma. Am J Respir Cell Mol Biol. 2010; 45(1):81-7. DOI: 10.1165/rcmb.2009-0392OC. View